The physical state of lipid nanoparticles influences their effect on in vitro cell viability

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 79, Issue 1, 2011, Pages 150-161

  Petersen, Silvia ^a   Steiniger, Frank ^a   Fischer, Dagmar ^a   Fahr, Alfred ^a   Bunjes, Heike ^b  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b TECHNICAL UNIVERSITY OF BRAUNSCHWEIG   (Germany)

Author keywords

Cell viability; Cytotoxicity; L929 mouse fibroblasts; Lipid nanoparticles; Particle shape; Physical state

Indexed keywords

CHOLESTEROL MYRISTATE; GLYCOCHOLATE SODIUM; LIPID; MYRISTIC ACID; NANOPARTICLE; PHOSPHOLIPID; POLOXAMER; POLYSORBATE 80; POLYVINYL ALCOHOL; TRIMYRISTIN; TRISTEARIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL TRANSPORT; CELL VIABILITY; DRUG EFFECT; DRUG FORMULATION; IN VITRO STUDY; MOUSE; NONHUMAN; PHYSICAL CHEMISTRY; SOYBEAN;

ANIMALS; CELL SURVIVAL; CHOLESTEROL ESTERS; DRUG CARRIERS; DRUG COMPOUNDING; DRUG EVALUATION, PRECLINICAL; EXCIPIENTS; FIBROBLASTS; FORMAZANS; HUMANS; LIPIDS; MICE; NANOPARTICLES; PARTICLE SIZE; PHOSPHOLIPIDS; POLYETHYLENE GLYCOLS; POLYSORBATES; POLYVINYL ALCOHOL; PROPYLENE GLYCOLS; TETRAZOLIUM SALTS; TRIGLYCERIDES;

EID: 80052190246     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2011.03.022     Document Type: Article

References (49)

1. S.M. Moghimi, A.C. Hunter, and J.C. Murray Nanomedicine: current status and future prospects FASEB J. 19 2005 311 330 (Pubitemid 40316520)
2. P.P. Constantinides, M.V. Chaubal, and R. Shorr Advances in lipid nanodispersions for parenteral drug delivery and targeting Adv. Drug Deliv. Rev. 60 2008 757 767
3. P. Couvreur, and C. Vauthier Nanotechnology: intelligent design to treat complex disease Pharm. Res. 23 2006 1417 1450 (Pubitemid 43993807)
4. W. Mehnert, and K. Mäder Solid lipid nanoparticles. Production, characterization and applications Adv. Drug Deliv. Rev. 47 2001 165 196 (Pubitemid 32324113)
5. H. Bunjes, and B. Siekmann Manufacture, characterization, and applications of solid lipid nanoparticles as drug delivery systems S. Benita, Drugs and the Pharmaceutical Sciences vol. 158 2006 CRC Press Boca Raton 213 268 (Microencapsulation - Methods and Industrial Applications, second ed.)
6. K. Westesen, and H. Bunjes Do nanoparticles prepared from lipids solid at room temperature always possess a solid lipid matrix? Int. J. Pharm. 115 1995 129 131
7. H. Bunjes, K. Westesen, and M.H.J. Koch Crystallization tendency and polymorphic transitions in triglyceride nanoparticles Int. J. Pharm. 129 1996 159 173 (Pubitemid 26098737)
8. K. Westesen, H. Bunjes, and M.H.J. Koch Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential J. Controlled Release 48 1997 223 236 (Pubitemid 27401980)
9. J. Kuntsche, K. Westesen, M. Drechsler, M.H.J. Koch, and H. Bunjes Supercooled smectic nanoparticles: a potential novel carrier system for poorly water soluble drugs Pharm. Res. 21 2004 1834 1843 (Pubitemid 39390096)
10. K. Westesen Novel lipid-based colloidal dispersions as potential drug administration systems - expectations and reality Colloid Polym. Sci. 278 2000 608 618 (Pubitemid 30458731)
11. K. Westesen, M. Drechsler, and H. Bunjes Colloidal dispersions based on solid lipids E. Dickinson, R. Miller, Food Colloids: Fundamentals of Formulation 2001 Royal Society of Chemistry Cambridge 103 115
12. H. Bunjes, F. Steiniger, and W. Richter Visualizing the structure of triglyceride nanoparticles in different crystal modifications Langmuir 23 2007 4005 4011 (Pubitemid 46581934)
13. K.M. Rosenblatt, and H. Bunjes Poly(vinyl alcohol) as emulsifier stabilizes solid triglyceride drug carrier nanoparticles in the α-modification Mol. Pharmaceutics 6 2008 105 120
14. J. Kuntsche, M.H.J. Koch, A. Fahr, and H. Bunjes Supercooled smectic nanoparticles: influence of the matrix composition and in vitro cytotoxicity Eur. J. Pharm. Sci. 38 2009 238 248
15. R.H. Müller, S. Maaßen, H. Weyhers, F. Specht, and J.S. Lucks Cytotoxicity of magnetite-loaded polylactide, polylactide/glycolide particles and solid lipid nanoparticles Int. J. Pharm. 138 1996 85 94 (Pubitemid 26241925)
16. N. Schöler, C. Olbrich, K. Tabatt, R.H. Müller, H. Hahn, and O. Liesenfeld Surfactant, but not the size of solid lipid nanoparticles (SLN) influences viability and cytokine production of macrophages Int. J. Pharm. 221 2001 57 67 (Pubitemid 32524035)
17. R.H. Müller, D. Rühl, S. Runge, K. Schulze-Forster, and W. Mehnert Cytotoxicity of solid lipid nanoparticles as a function of the lipid matrix and the surfactant Pharm. Res. 14 1997 458 462 (Pubitemid 27205004)
18. N. Schöler, H. Hahn, R.H. Müller, and O. Liesenfeld Effect of lipid matrix and size of solid lipid nanoparticles (SLN) on the viability and cytokine production of macrophages Int. J. Pharm. 231 2002 167 176 (Pubitemid 34033676)
19. A.V. Heydenreich, R. Westmeier, N. Pedersen, H.S. Poulsen, and H.G. Kristensen Preparation and purification of cationic solid lipid nanospheres - effects on particle size, physical stability, and cell toxicity Int. J. Pharm. 254 2003 83 87 (Pubitemid 36259816)
20. W. Weyenberg, P. Filev, D. Van den Plas, J. Vandervoort, K. De Smet, P. Sollie, and A. Ludwig Cytotoxicity of submicron emulsions and solid lipid nanoparticles for dermal application Int. J. Pharm. 337 2007 291 298 (Pubitemid 46756044)
21. H. Weyhers, S. Ehlers, H. Hahn, E.B. Souto, and R.H. Müller Solid lipid nanoparticles (SLN) - effects of lipid composition on in vitro degradation and in vivo toxicity Pharmazie 61 2006 539 544 (Pubitemid 43989132)
22. L.S.C. Wan, and P.F.S. Lee CMC of polysorbates J. Pharm. Sci. 63 1974 136 137
23. J.H. Finley Spectrophotometric determination of poly(vinyl alcohol) in paper coatings Anal. Chem. 33 1961 1925 1927
24. G. Dalwadi, H.A.E. Benson, and Y. Chen Comparison of diafiltration and tangential flow filtration for purification of nanoparticle suspensions Pharm. Res. 22 2005 2152 2162 (Pubitemid 41821595)
25. T. Mosmann Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays J. Immunol. Methods 65 1983 55 63 (Pubitemid 14203433)
26. D. Fischer, Y. Li, B. Ahlemeyer, J. Krieglstein, and T. Kissel In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis Biomaterials 24 2003 1121 1131 (Pubitemid 36069121)
27. ISO 10993-5: 2009, Biological evaluation of medical devices - part 5: tests for in vitro cytotoxicity, 2009.
28. E.H. Gokce, G. Sandri, M.C. Bonferoni, S. Rossi, F. Ferrari, T. Gueneri, and C. Caramella Cyclosporine A loaded SLNs: evaluation of cellular uptake and corneal cytotoxicity Int. J. Pharm. 364 2008 76 86
29. J. Kristl, K. Teskac, M. Milek, and I. Mlinaric-Rascan Surface active stabilizer Tyloxapol in colloidal dispersions exerts cytostatic effects and apoptotic dismissal of cells Toxicol. Appl. Pharmacol. 232 2008 218 225
30. H. Bunjes Characterization of solid lipid nano- and microparticles C. Nastruzzi, 2005 CRC Press LLC Boca Raton 41 66
31. K. Westesen, and B. Siekmann Investigation of the gel formation of phospholipid-stabilized solid lipid nanoparticles Int. J. Pharm. 151 1997 35 45 (Pubitemid 27212302)
32. A. Petri-Fink, B. Steitz, A. Finka, J. Salaklang, and H. Hofmann Effect of cell media on polymer coated superparamagnetic iron oxide nanoparticles (SPIONs): colloidal stability, cytotoxicity, and cellular uptake studies Eur. J. Pharm. Biopharm. 68 2008 129 137 (Pubitemid 350181416)
33. F. Liu, and D. Liu Long-circulating emulsions (oil-in-water) as carriers for lipophilic drugs Pharm. Res. 12 1995 1060 1064
34. S. Petersen, H. Bunjes, Stability of different lipid nanoparticle formulations in various media, in: Controlled Release Society German Chapter Annual Meeting: Jena, Controlled Release Society Germany Local Chapter, 2006, Abstract P17.
35. J. Kuntsche, M.H.J. Koch, M. Drechsler, and H. Bunjes Crystallization behavior of supercooled smectic cholesteryl myristate nanoparticles containing phospholipids as stabilizers Colloids and Surfaces B: Biointerfaces 44 2005 25 35 (Pubitemid 40968096)
36. J. Kuntsche, M.H.J. Koch, F. Steiniger, and H. Bunjes Influence of stabilizer systems on the properties and phase behavior of supercooled smectic nanoparticles J. Colloid Interface Sci. 350 2010 229 239
37. M. Wirtitsch, B. Wessner, A. Spittler, E. Roth, T. Volk, L. Bachmann, and M. Hiesmayr Effect of different lipid emulsions on the immunological function in humans: a systematic review with meta-analysis Clin. Nutr. 26 2007 302 313 (Pubitemid 46760482)
38. B. Dupont Overview of the lipid formulations of amphotericin B J. Antimicrob. Chemother. 49 2002 31 36 (Pubitemid 34162654)
39. U. Julius, and W. Leonhardt Elimination and metabolism of a fat emulsion containing medium chain triglycerides (Lipofundin MCT 10%) J. Parenteral Enteral Nutr. 12 1988 116 120 (Pubitemid 18087278)
40. N. Schöler, E. Zimmermann, U. Katzfey, H. Hahn, R.H. Müller, and O. Liesenfeld Preserved solid lipid nanoparticles (SLN) at low concentrations do cause neither direct nor indirect cytotoxic effects in peritoneal macrophages Int. J. Pharm. 196 2000 235 239 (Pubitemid 30105751)
41. S.D. Singh-Joy, and V.C. Mclain Safety assessment of poloxamers 101, 105, 108, 122, 123, 124, 181, 182, 183, 184, 185, 188, 212, 215, 217, 231, 234, 235, 237, 238, 282, 284, 288, 331, 333, 334, 335, 338, 401, 402, 403, and 407, poloxamer 105 benzoate, and poloxamer 182 dibenzoate as used in cosmetics Int. J. Toxicol. 27 2008 93 128
42. J.D. Michaels, and E.T. Papoutsakis Polyvinyl alcohol and polyethylene glycol as protectants against fluid-mechanical injury of freely-suspended animal cells (CRL 8018) J. Biotechnol. 19 1991 241 257
43. S.A. Maskarinec, J. Hannig, R.C. Lee, and K.Y. Lee Direct observation of poloxamer 188 insertion into lipid monolayers Biophys. J. 82 2002 1453 1459 (Pubitemid 34204765)
44. G. Serbest, J. Horwitz, M. Jost, and K.A. Barbee Mechanisms of cell death and neuroprotection by poloxamer 188 after mechanical trauma FASEB J. 20 2006 308 310 10 (Pubitemid 46671153)
45. S.L. Frey, D. Zhang, M.A. Carignano, I. Szleifer, and K.Y. Lee Effects of block copolymer's architecture on its association with lipid membranes: experiments and simulations J. Chem. Phys. 127 2007 114904-1-114904/12
46. Y. Shintani, K. Iwamoto, and K. Kitano Polyethylene glycols for promoting the growth of mammalian cells Appl. Microbiol. Biotechnol. 27 1988 533 537 (Pubitemid 18046582)
47. S.I. Simoes, J.M. Tapadas, C.M. Marques, M.E.M. Cruz, M.B.F. Martins, and G. Cevc Permeabilisation and solubilisation of soybean phosphatidylcholine bilayer vesicles, as membrane models, by polysorbate, Tween 80 Eur. J. Pharm. Sci. 26 2005 307 317 (Pubitemid 41282799)
48. L. Joergensen, P. Artursson, and E. Bechgaard Toxicological and absorption enhancing effects of Glycofurol 75 and sodium glycocholate in monolayers of human intestinal epithelial (Caco-2) cells Int. J. Pharm. 95 1993 209 217 (Pubitemid 23203154)
49. J.A. Champion, Y.K. Katare, and S. Mitragotri Particle shape: a new design parameter for micro- and nanoscale drug delivery carriers J. Controlled Release 121 2007 3 9 (Pubitemid 47126059)